GAMMA Investing’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Sell
214
-66
-24% -$3.75K ﹤0.01% 3014
2026
Q1
$18K Sell
280
-28
-9% -$2.55K ﹤0.01% 2765
2025
Q4
$40.1K Buy
308
+59
+24% +$8.1K ﹤0.01% 2216
2025
Q3
$26.8K Buy
249
+37
+17% +$4.03K ﹤0.01% 2373
2025
Q2
$19.6K Sell
212
-226
-52% -$17.7K ﹤0.01% 2471
2025
Q1
$38.8K Buy
438
+264
+152% +$22.9K ﹤0.01% 1975
2024
Q4
$13.4K Buy
174
+59
+51% +$4.12K ﹤0.01% 2462
2024
Q3
$4.88K Buy
+115
New +$3.88K ﹤0.01% 2753

Other funds holding WGS

GAMMA Investing's WGS Position: Q2 2026 in Review

GAMMA Investing reduced its GeneDx Holdings (WGS) stake by 24% in Q2 2026, selling an estimated $3.75K and leaving 214 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

GAMMA Investing first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $40.1K in Q4 2025. 25 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • GAMMA Investing held 214 shares of GeneDx Holdings worth $14.7K as of Q2 2026.
  • GAMMA Investing sold 66 GeneDx Holdings shares in Q2 2026, an estimated $3.75K.
  • GeneDx Holdings made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3014 holding.
  • GAMMA Investing first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
  • GAMMA Investing's GeneDx Holdings position peaked at $40.1K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.